Related Experiment Video
Updated: Dec 5, 2025
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
An Integrative Gene Expression and Mathematical Flux Balance Analysis Identifies Targetable Redox Vulnerabilities in
B Bishal Paudel1,2,3, Joshua E Lewis4, Keisha N Hardeman1,2
1Department of Biochemistry, Vanderbilt University, Nashville, Tennessee.
Abstract:
Melanomas harboring BRAF mutations can be treated with BRAF inhibitors (BRAFi), but responses are varied and tumor recurrence is inevitable. Here we used an integrative approach of experimentation and mathematical flux balance analyses in BRAF-mutated melanoma cells to discover that elevated antioxidant capacity is linked to BRAFi sensitivity in melanoma cells. High levels of antioxidant metabolites in cells with reduced BRAFi sensitivity confirmed this conclusion. By extending our analyses to other melanoma subtypes in The Cancer Genome Atlas, we predict that elevated redox capacity is a general feature of melanomas, not previously observed. We propose that redox vulnerabilities could be exploited for therapeutic benefits and identify unsuspected combination targets to enhance the effects of BRAFi in any melanoma, regardless of mutational status. SIGNIFICANCE: An integrative bioinformatics, flux balance analysis, and experimental approach identify targetable redox vulnerabilities and show the potential for modulation of cancer antioxidant defense to augment the benefits of existing therapies in melanoma.
Insights
Melanoma cells with high antioxidant capacity are sensitive to BRAF inhibitors. Targeting these redox vulnerabilities may improve BRAF inhibitor effectiveness in all melanoma patients.
Area of Science:
- Oncology
- Biochemistry
- Bioinformatics
Background:
- Melanomas with BRAF mutations are treated with BRAF inhibitors (BRAFi).
- Treatment responses to BRAFi are variable, and tumor recurrence is common.
- Understanding resistance mechanisms is crucial for improving melanoma therapy.
Purpose of the Study:
- To investigate the link between antioxidant capacity and BRAF inhibitor sensitivity in melanoma.
- To identify novel therapeutic targets for enhancing BRAFi efficacy.
- To explore redox vulnerabilities as a general feature across melanoma subtypes.
Main Methods:
- Integrative approach combining experimental data and mathematical flux balance analysis.
- Analysis of BRAF-mutated melanoma cell lines.
- Examination of The Cancer Genome Atlas (TCGA) data for diverse melanoma subtypes.
Main Results:
- Elevated antioxidant capacity correlates with BRAF inhibitor sensitivity in melanoma cells.
- High levels of antioxidant metabolites were observed in cells with reduced BRAFi sensitivity.
- Redox capacity is predicted to be a general, previously unrecognized feature of melanomas.
Conclusions:
- Targetable redox vulnerabilities exist in melanoma.
- Modulating cancer antioxidant defense can enhance BRAFi benefits.
- Novel combination targets can be identified to improve BRAFi therapy for all melanomas.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...